U.S., Feb. 1 -- ClinicalTrials.gov registry received information related to the study (NCT06802796) titled 'Plasma NGAL in APN Patients' on Jan. 25.
Brief Summary: In recent years, novel biomarkers of renal dysfunction have attracted attention for the diagnosis of UTIs. NGAL is a 25 kDa protein that belongs to the lipocalin. It acts as a transporter for small hydrophobic molecules and is involved in many physiological processes, such as modulating inflammation, innate immune response, and maintaining metabolic homeostasis
Study Start Date: Feb. 01, 2024
Study Type: OBSERVATIONAL
Condition:
Pyelonephritis
Intervention:
DIAGNOSTIC_TEST: Plasma NGAL test
Human neutrophil gelatinase-associated lipocalin ELISA Kit from BT LAB(R) Bioassay...